| 07.50-08.00 |
Ethical Issues in Managing Hypertension
Pukovisa Prawiroharjo |
| 08.00-08.40 |
Morning Talks On Hypertension
Zulkhair Ali |
| 08.00 - 08.10 |
Resistant Hypertension: A Practical Clinical Approach for Diagnosis and Treatment
Interactive Case Study 1: Resistant Hypertension
Case Presenter: Anandhara Indriani K
Panelists: Sari Mumpuni, Chandra Irawadi M, Yuda Turana
|
| 08.30 - 08.40 |
Discussion |
| 08.40-09.30 |
Plenary Session
Wiguno Prodjosudjadi |
| 08.40 - 09.05 |
How to manage hypertension in 2025: International consensus?
George Stergiou (International Society of Hypertension)
|
| 09.05 - 09.30 |
Primordial Hypertension: shaping national health strategies for prevention and management
Teguh Ranakusuma
|
| 09.30-10.00 |
Opening Ceremony |
| 10.00-10.30 |
Coffee Break |
| 10.30-11.30 |
Symposium 1
Consequences of Hypertension to the Brain, Heart and Kidney: Strategies to Improve Outcomes
Chair:
Lisda Amalia, MD
|
Symposium 2
Hypertension and Dyslipidemia as a Double Burden of Cerebro Vascular Disease
Chair:
Jose Roesma, MD
|
Symposium 3
Navigating the Complex Relationship: Heart Failure and Cardiorenal Syndrome
Chair:
Erwinanto, MD
|
| 10:30 - 10:45 |
(OC) Stroke Prevention in Heart Failure Patients
Rahmat Hidayat |
(OC) Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Bambang Purwanto |
(OC) Updates on Cardiorenal Continuum
Ria Bandiara |
| 10:45 - 11:00 |
Tackling HFrEF: Tactics for superior long-term outcomes
Rossana Barack |
Updated Pharmacological Approaches to Hypertension Management
Yenny Kandarini |
Unlocking Hope Across Heart Failure's Ejection Fractions: Dapagliflozin's Position on Latest Guideline Therapy
Badai Tiksnadi |
| 11:00 - 11:15 |
ARNI in patients with HFrEF and renal impairment: where do we stand?
Sally A. Nasution |
Comprehensive Treatment of Stroke related to Hypertension and Dyslipidemia
Mursyid Bustami |
Advancements in Hyperkalemia Management for Cardiorenal Syndrome: New Therapeutic Strategies
Ginnova Nainggolan |
| 11:15 - 11:30 |
Discussion |
Discussion |
Discussion |
| 11.30-12.30 |
Lunch Symposium 1
JOINT SESSION InaSH - ISH and HOPE ASIA NETWORK
Chair:
Anwar Santoso, MD
|
Lunch Symposium 2
Mastering Hypertension: Innovations and Strategies for Optimal Blood Pressure Control
Chair:
Yuda Turana, MD
|
Lunch Symposium 3
Pioneering Cerebrocardiorenal Complications in Hypertension
Chair:
Ekawatidani Yulianti, MD
|
| 11:30 - 11:45 |
Current issues and future perspectives in blood pressure measurement and hypertension diagnosis
George Stergiou (International Society of Hypertension) |
Integrative Strategies from the ESH 2024 MASTERplan
Claudio Borghi (European Society of Hypertension) |
Guardian of the heart - our superpower in managing all spectrum HF
Siska Suridanda Dany |
| 11:45 - 11:50 |
Protector of the kidney - easing our CKD patients
Pranawa Martosuwignyo |
| 11:50 - 12:00 |
Use of angiotensin-receptor neprilysin inhibitor for the management of hypertension
Jiguang Wang (HOPE Asia Network) |
Multiple Power on Blood Pressure Control to Prevent Cardio-Renal Complications
Djoko Wibisono |
| 12:00 - 12:10 |
Tackling the scourge of CVD and CKD with the duo force
Yan Herry |
| 12:10 - 12:15 |
Discussion |
Discussion |
| 12:15 - 12:30 |
Discussion |
| 12.30-13.30 |
Lunch |
| 13.30-14.30 |
Symposium 4
ACE Inhibitor and Beta Blocker in the Management of Hypertension
Chair:
Ni Made Hustrini, MD
|
Symposium 5
Exploring Gut Hypertension Axis: Integrating Single Pill Combinations For Optimized CV Management
Chair:
Nyoman Paramita Ayu, MD
|
Symposium 6
Burden of Hypertension to Brain, Heart and Kidney
Chair:
Santoso Karo Karo, MD
, Co-Chair:
Dinda Diafiri, MD
|
| 13:30 - 13:45 |
(OC) Interaction Between the Symphatetic Nervous System and Renin Angiotensin Aldosterone in Hypertension
Zulkhair Ali |
(OC) Exploring New Therapeutic Options of Microbiota - Derived Metabolites in Blood Pressure Regulation
Afiatin |
(OC) New Insight into Cerebrovascular Pathophysiology in Hypertension
Cep Juli |
| 13:45 - 14:00 |
Upstream and Downstream Pathway Intervention in controlling Hypertension and Preventing the complication: The Power of ACE-i
Saifur Rohman |
Understanding the Link Between TMAO and Cardiovascular Disease: From Pathophysiology to Therapeutic Strategies
Bambang Widyantoro |
Optimizing Telmisartan in Managing Hypertension: Beyond Blood Pressure Lowering Effect
Pringgodigdo Nugroho |
| 14:00 - 14:15 |
The Role of Vasodilator Beta Blocker as Anti Hypertensive Agents in Specific Population (Nebivolol)
Paskariatne Probodewi |
Improving Hypertension Treatment and Control: the challenge and how to overcome it with Single Pill Combination
Haerani Rasyid |
How to Improve Management of Hypertension Related Proteinuria
Tunggul D. Situmorang |
| 14:15 - 14:30 |
Discussion |
Discussion |
Discussion |
| 14.30-15.30 |
Symposium 7
The Innovations in Hypertension Monitoring
Chair:
Tunggul D. Situmorang, MD
|
Symposium 8
Evidence to Practice: Renal Denervation as a treatment for Hypertension
Chair:
Amanda Tiksnadi, MD
|
Symposium 9
Management of ASCVD and Type 2 Diabetes
Chair:
Yulia Sofiatin, MD
|
| 14:30 - 14:45 |
Machine Learning Models for Early Detection and Diagnosis in Hypertension
I Made Putra Swi Antara |
(OC) Recent Update on Resistant Hypertension
Bagus Andi Pramono |
(OC) Managing Hypertension in Diabetes: Strategies for Integreted Care and Optimal Outcomes
Rudi Supriyadi |
| 14:45 - 15:00 |
Cuffless Blood Pressure Monitoring Device for Better Hypertension Control
Hae Young Lee (Korean Society of Hypertension) |
The Evidence : The Spyral HTN Clinical program
Faris Basalamah |
Managing People with ASCVD and Type 2 Diabetes: What Do Recent Guidelines Say
Antonia Anna Lukito |
| 15:00 - 15:15 |
The Early Echocardiographic Signs in Hypertensive Heart Disease
BRM Ario Soeryo |
Selecting the right patients for Renal Denervation
Maruhum Bonar Marbun |
GLP-1 RA Semaglutide Once-Weekly: A Novel Treatment Choice for People with ASCVD and T2D
Dicky Tahapary |
| 15:15 - 15:30 |
Discussion |
Discussion |
Discussion |
| 15.30-15.45 |
Wrap Up |
| 15.45-16.00 |
Doorprize |
